CIPLA — Cipla Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapHigh Flyer

Annual income statement for Cipla, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	171,320	191,596	217,633	227,531	257,741
Cost of Revenue
Gross Profit	101,952	108,310	122,026	134,389	158,169
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	150,912	159,601	184,306	190,470	207,150
Operating Profit	20,408	31,995	33,327	37,061	50,591
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	21,782	32,901	34,933	40,384	57,019
Provision for Income Taxes
Net Income After Taxes	15,470	24,013	25,595	28,355	41,553
Minority Interest
Equity in Affiliates
Net Income Before Extraordinary Items
Net Income	15,465	24,049	25,168	28,019	41,216
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	15,465	24,049	25,168	28,019	41,216
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	19.8	30.3	33.3	37.4	53.8
Dividends per Share
Special Dividends per Share